Literature DB >> 11000042

Efficient, highly enantioselective synthesis of selina-1,3, 7(11)-trien-8-one, a major component of the essential oil of Eugenia uniflora.

A Kanazawa1, A Patin, A E Greene.   

Abstract

The first synthesis of selina-1,3,7(11)-trien-8-one (1), a major constituent of the essential oil from the leaves of Eugenia uniflora, has been accomplished, with excellent stereo- and regiocontrol, in eight steps and in 12% overall yield from the known octalone derivative 2a.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11000042     DOI： 10.1021/np000065f

Source DB:  PubMed          Journal:  J Nat Prod        ISSN： 0163-3864            Impact factor:   4.050


  4 in total

1.  Antioxidant activity of five Brazilian plants used as traditional medicines and food in Brazil.

Authors:  Allana K L Santos; José G M Costa; Irwin R A Menezes; Isaac F Cansanção; Karla K A Santos; Edinardo F F Matias; Henrique D M Coutinho
Journal:  Pharmacogn Mag       Date:  2010-10       Impact factor: 1.085

2.  Chemical composition and antibacterial activity of essential oils of Eugenia species.

Authors:  Michele D A Magina; Eduardo M Dalmarco; Alberto Wisniewski; Edesio L Simionatto; Juliana B Dalmarco; Moacir G Pizzolatti; Inês M C Brighente
Journal:  J Nat Med       Date:  2009-03-24       Impact factor: 2.343

3.  Selina-1,3,7(11)-trien-8-one and Oxidoselina-1,3,7(11)-trien-8-one from Eugenia uniflora Leaf Essential Oil and Their Cytotoxic Effects on Human Cell Lines.

Authors:  Jociani Ascari; Marcos Felipe Maciel Pereira; Vinicius Monteiro Schaffka; Domingos Sávio Nunes; Cássia Gonçalves Magalhães; Jânio Sousa Santos; Daniel Granato; Mariana Araújo Vieira do Carmo; Luciana Azevedo; Marcos Vinicio Lopes Rodrigues Archilha; Dilamara Riva Scharf
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

4.  Analysis of Flavonoids from Eugenia uniflora Leaves and Its Protective Effect against Murine Sepsis.

Authors:  Yanna D Rattmann; Lauro Mera de Souza; Simone M Malquevicz-Paiva; Nessana Dartora; Guilherme Lanzi Sassaki; Philip A J Gorin; Marcello Iacomini
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.